Skip to main content
SpringerLink
Log in

Hepatopulmonary syndrome

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

The hepatopulmonary syndrome (HPS) is an important and often under-recognized vascular complication of cirrhosis and portal hypertension characterized by pulmonary vascular dilatation, which results in hypoxemia. This syndrome is identified in as many as 20% of patients who are evaluated for orthotopic liver transplantation (OLT), and it has recently been found to increase mortality in affected patients, particularly when hypoxemia is severe. Currently, OLT is the only therapy established to reverse intrapulmonary vasodilatation, although postoperative mortality is increased in patients with severe hypoxemia. No randomized controlled trials of pharmacologic therapies have been undertaken, but supplemental oxygen improves oxygenation. Data derived from case reports, small studies, and experimental models suggest that pharmacologic therapies may be effective. In cirrhotic patients with HPS, particularly those with moderate hypoxemia (PaO2 < 60 mmHg), OLT should be considered prior to the development of severe deoxygenation. Supplemental oxygen should be given to patients with a PaO2 < 60 mmHg or those with exercise oxygen desaturation. For those patients with mild hypoxemia or those who are not OLT candidates, a trial of pharmacologic treatment may be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lange PA, Stoller JK: The hepatopulmonary syndrome. Ann Intern Med 1995, 122: 521–529.

    PubMed  CAS  Google Scholar 

  2. Rodriguez-Roison R, Agusti AG, Roca J: The hepatopulmonary syndrome: new name, old complexities. Thorax 1992, 47: 897–902.

    Google Scholar 

  3. Fluckiger M: Vorkommen von trommelschagel formigen fingerendphalangen ohne chronische veranderungen an der lungen oder am herzen. Wien Med Wochenschr 1884, 34: 1457.

    Google Scholar 

  4. Kennedy TC, Knudson RJ: Exercise aggregated hypoxemia and orthodeoxia in cirrhosis. Chest 1977, 72: 305.

    PubMed  CAS  Google Scholar 

  5. Abrams GA, Jaffe CC, Hoffer PB, et al.: Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995, 109: 1283–1288.

    Article  PubMed  CAS  Google Scholar 

  6. Abrams G, Nanda N, Dubovsky E, et al.: Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome:a new approach. Gastroenterology 1998, 114: 305–310.

    Article  PubMed  CAS  Google Scholar 

  7. Schenk P, Schoniger-Hekele M, Fuhrmann V, et al.: Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003, 125: 1042–1052. This is the first study to document that the presence of HPS increases mortality in cirrhosis. This data provide a rationale for screening for HPS in this population.

    Article  PubMed  Google Scholar 

  8. Martinez G, Barbera J, Visa J, et al.: Hepatopulmonary Syndrome in candidates for liver transplantation. J Hepatol 2001, 34: 756–758.

    Article  Google Scholar 

  9. Krowka M, Wiseman G, Burnett O, et al.: Hepatopulmonary syndrome: A prospective study of relationships between severity of liver disease, Pao2 response to 100% oxygen, and brain uptake after 99mTc MAA lung scanning. Chest 2000, 118: 615–624.

    Article  PubMed  CAS  Google Scholar 

  10. Whyte M, Hughes J, Peters A, et al.: Analysis of intrapulmonary right to left shunt in hepatopulmonary syndrome. J Hepatol 1998, 29: 85–93.

    Article  PubMed  CAS  Google Scholar 

  11. Dimand RJ, Heyman MB, Bass NM, et al.: Hepatopulmonary syndrome: response to hepatic transplantation [abstract]. Hepatology 1991, 141: 55A.

    Google Scholar 

  12. Abrams G, Fallon M: The hepatopulmonary syndrome. Clin Liv Dis 1997, 1: 185–200.

    Article  CAS  Google Scholar 

  13. Binay K, Sen S, Biswas PK, et al.: Hepatopulmonary syndrome in inferior vena cava obstruction responding to cavoplasty. Gastroenterology 2000, 118: 192–196.

    Article  Google Scholar 

  14. Gupta D, Vijaya DR, Gupta R, et al.: Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. Am J Gastroenterol 2001, 96: 3395–3399.

    Article  PubMed  CAS  Google Scholar 

  15. Regev A, Yeshurun M, Rodriguez M, et al.: Transient hepatopulmonary syndrome in a patient with acute hepatitis A. J Viral Hep 2001, 8: 83–86.

    Article  CAS  Google Scholar 

  16. Teuber G, Teupe C, Dietrich C, et al.: Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. Eur J Intern Med 2002, 13: 311–318.

    Article  PubMed  Google Scholar 

  17. Schraufnagel D, Kay J: Structural and pathologic changes in the lung vasculature in chronic liver disease. Clin Chest Med 1996, 17: 1–15.

    Article  PubMed  CAS  Google Scholar 

  18. Herve P, Lebrec D, Brenot F, et al.: Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998, 11: 1153–1166.

    Article  PubMed  CAS  Google Scholar 

  19. Budhiraja R, Hassoun PM: Portopulmonary hypertension: a tale of two circulations. Chest 2003, 123: 562–576.

    Article  PubMed  Google Scholar 

  20. Zhang M, Luo B, Chen SJ, et al.: Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. Am J Physiol 1999, 277: G944-G952.

    PubMed  CAS  Google Scholar 

  21. Luo B, Liu L, Tang L, et al.: Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. Hepatology 2003, 38: 556–563.

    Article  CAS  Google Scholar 

  22. Ling Y, Zhang J, Luo B, et al.: The role of endothelin-1 and the endothelin B receptor in the pathogenesis of experimental hepatopulmonary syndrome. Hepatology 2004, 39: 1593–1602.

    Article  PubMed  CAS  Google Scholar 

  23. Rabiller A, Nunes H, Lebrec D, et al.: Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002, 166: 514–517.

    Article  PubMed  Google Scholar 

  24. Nunes H, Lebrec D, Mazmanian M, et al.: Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001, 164: 879–885.

    PubMed  CAS  Google Scholar 

  25. Zhang J, Ling Y, Luo B, et al.: Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 2003, 125: 1441–1451.

    Article  PubMed  CAS  Google Scholar 

  26. Fallon MB, Abrams GA, Luo B, et al.: The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997, 113: 606–614.

    Article  PubMed  CAS  Google Scholar 

  27. Carter EP, Hartsfield CL, Miyazono M, et al.: Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2002, 283: L346-L353.

    PubMed  CAS  Google Scholar 

  28. Krowka MJ, Dickson ER, Cortese DA: Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest 1993, 104: 515–521.

    PubMed  CAS  Google Scholar 

  29. Swanson K, Wiesner R, Krowka M: Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology 2005, 41: 1122–1129.

    Article  PubMed  Google Scholar 

  30. Arguedas M, Abrams GA, Krowka MJ, Fallon MB: Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003, 37: 192–197. This is the first prospective study to document the effects of HPS on survival after OLT in cirrhosis. The findings support that postoperative mortality increases as hypoxemia worsens and underscore the need for recognition and consideration of therapy early in the course of disease.

    Article  PubMed  Google Scholar 

  31. Gaines DI, Fallon MB: Hepatopulmonary syndrome. Liver Int 2004, 24: 397–401. Concise, focused review of clinical presentation, diagnosis, and management of HPS. A useful primer on this disorder.

    Article  PubMed  Google Scholar 

  32. Abrams GA, Sanders MK, Fallon MB: Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl 2002, 8: 391–396.

    Article  PubMed  Google Scholar 

  33. Garcia-Tsao G: Portal hypertension. Curr Opin Gastroenterol 2005, 21: 313–322.

    Article  PubMed  Google Scholar 

  34. Tazi K, Barriere E, Moreau R, et al.: Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. Gastroenterology 2002, 122: 1869–1877.

    Article  PubMed  CAS  Google Scholar 

  35. Anel RM, Sheagren JN: Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents. Clin Infect Dis 2001, 32: E131-E136.

    Article  PubMed  CAS  Google Scholar 

  36. Abrams GA, Fallon MB: Treatment of hepatopulmonary syndrome with allium sativum L. (garlic): A pilot trial. J Clin Gastro 1998, 27: 232–235.

    Article  CAS  Google Scholar 

  37. Lange PA, Stoller JK: The Hepatopulmonary Syndrome: effect of liver transplantation. Clin Chest Med 1996, 17: 115–123.

    Article  PubMed  CAS  Google Scholar 

  38. Mandell MS, Groves BM, Duke J: Progressive plexogenic pulmonary hypertension following liver transplantation. Transplantation 1995, 59: 1488–1490.

    PubMed  CAS  Google Scholar 

  39. Abrams GA, Rose K, Fallon MB, et al.: Hepatopulmonary syndrome and venous emboli causing intracerebral hemorrhages after liver transplantation: a case report. Transplantation 1999, 68: 1–3.

    Article  Google Scholar 

  40. Scott V, Mira A, Kang Y, et al.: Reversibility of the hepatopulmonary syndrome by orthotopic liver transplantation. Transplant Proc 1993, 25: 1787–1788.

    PubMed  CAS  Google Scholar 

  41. Philit F, Wiesendanger T, Gille D, et al.: Late resolution of hepatopulmonary syndrome after liver transplantation. Respiration 1997, 64: 173–175.

    Article  PubMed  CAS  Google Scholar 

  42. Reigler JL, Lang KA, Johnson SP, Westerman JH: Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome. Gastroenterol 1995, 109: 978–983.

    Article  Google Scholar 

  43. Selim KM, Akriviadis EA, Zuckerman E, et al.: Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. Am J Gastro 1998, 93: 455–458.

    Article  CAS  Google Scholar 

  44. Allgaier HP, Haag K, Ochs A, et al.: Hepatopulmonary syndrome: Successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS). J Hepatol 1995, 23: 102–105.

    Article  PubMed  CAS  Google Scholar 

  45. Paramesh A, Hussain S, Shneider B, et al.: Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: Case report and review of literature. Pediatr Transplant 2003, 7: 157–162.

    Article  PubMed  Google Scholar 

  46. Chevallier P, Novelli L, Motamedi JP, et al.: Hepatopulmonary syndrome successfully treated with transjugular intrahepatic portosystemic shunt: a three-year follow-up. J Vasc Interv Radiol 2004, 15: 647–648.

    PubMed  Google Scholar 

  47. Corley DA, Scharschmidt B, Bass N, et al.: Lack of efficacy of TIPS for hepatopulmonary syndrome. Gastroenterol 1997, 113: 728–731.

    Article  CAS  Google Scholar 

  48. Poterucha JJ, Krowka MJ, Dickson ER, et al.: Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology 1995, 21: 96–100.

    PubMed  CAS  Google Scholar 

  49. Ryu JK, Oh JH: Hepatopulmonary syndrome: Angiography and therapeutic embolization. Clin Imaging 2003, 27: 97–100.

    Article  PubMed  Google Scholar 

  50. Sztrymf B, Rabiller A, Nunes H, et al.: Prevention of hepatopulmonary syndrome by pentoxifylline in cirrhotic rats. Eur Respir J 2004, 23: 752–758.

    Article  PubMed  CAS  Google Scholar 

  51. Brussino L, Bucca C, Morello M, et al.: Effect on dyspnoea and hypoxaemia of inhaled NG-nitro-Larginine methyl ester in hepatopulmonary syndrome. Lancet 2003, 362: 43–44.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology/Hepatology, University of Alabama at Birmingham, MCLM 290, 1530 3rd Avenue South, 35294, Birmingham, AL, USA

    Miguel R. Arguedas MD & Michael B. Fallon MD

Authors
  1. Miguel R. Arguedas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael B. Fallon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arguedas, M.R., Fallon, M.B. Hepatopulmonary syndrome. Curr Treat Options Gastro 8, 451–456 (2005). https://doi.org/10.1007/s11938-005-0031-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-005-0031-y

Keywords

Search

Navigation